Ardis Ann Moe, M.D. UCLA CARE Clinic/NEVHC HIV Clinic Van Nuys. 29 August 2014

Slides:



Advertisements
Similar presentations
TUBERCULOSIS This is the prompt slide for the TB Therapy section.
Advertisements

Hepatitis B & Hepatitis C in HIV
If client wants to know more about the mini-pill, go to next page.
HIV and Hep C testing Ardis Moe, M.D. UCLA CARE/NEVHC Van Nuys HIV Clinic Friday 20 June, 2014.
Heather D. Mannuel, MD, MBA March 12, 2008
Drug Side Effects, Toxicities, and Interactions
Ardis Ann Moe UCLA CARE clinic/NEVHC Van Nuys 21 June 2014
Pre Test !!!!!!. How many classes of HIV meds are currently available?
Women and Adolescents Case Presentations Vivian M Tamayo-Agrait, MD, FACOG, AAHIVMS Department of Obstetrics and Gynecology University of Puerto Rico Faculty,
Antiretroviral drugs in UMMC Presenter: TE CHIN YEW Preceptor: KHOO SU LIN.
Traveler with a fever Case presentation Ann Schmidt.
Stroke Awareness.
How to Interpret Your Lab Results Presented by Pat Hogan, ARNP, AAHIVS Group Health Cooperative.
Drugs for HIV/AIDS management Dorothy Rodriguez, Emmelisa Gonzalez, Wilfrido Cordova.
COMMON LIFESTYLE DISEASES
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
+ Understanding HIV-Related Lab Tests Jordan E. Lake, MD, MSc AAHU August 27, 2014.
1. What is the most common mode of HIV transmission? 2. How else is HIV transmitted? 3. What is the most common mode of work related transmission? p.
1 Side Effects of Anti-retroviral Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Adverse Reactions & Antiretroviral Therapy Kirsten B. Balano, PharmD October 26, 2002.
Greenview Hepatitis C Fund Deborah Green Home: Cell: /31/2008.
Ambulatory Care Pharmacy
Major Depressive Disorder Presenting Complaints
HIV/ AIDS Answers to your questions. What is HIV HIV- Human Immunodeficiency Virus HIV- Human Immunodeficiency Virus The virus attacks the T-Cells in.
HIV and AIDS Global: 40M HIV positive 25M AIDS deaths from ‘80 (60% sub-Saharan Africa) 80+% male Canada:63K HIV positive 16K AIDS deaths since 1980 (83%
Introduction to ARV therapy
HIV opportunistic infections and HIV treatment Sabrina Assoumou, MD Section of Infectious Diseases.
Symptom Control of Cancer Treatment
Ardis Ann Moe, M.D. UCLA CARE clinic/NEVHC Van Nuys HIV Clinic 28 August 2015.
Ardis Ann Moe, M.D. UCLA CARE Clinic/NEVHC HIV Clinic Van Nuys. 28 August 2015
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 93 Antiviral Agents II: Drugs for HIV Infection and Related.
Background Collection of S & O Information Data: – CC, HPI, PMH, PSHx, Demographics – Medication history including compliance etc. – VS, ROS, Lab, other.
Module 4 Basic Principles of Treatment. “ubo! ubo! ubo!” (cough for 2 weeks or more) Did not take medication medication In Loving Memory of In Loving.
Pediatric Endocrinology Use of Biologic and Chemotherapeutic Agents Pediatric Endocrinology Use of Biologic and Chemotherapeutic Agents.
When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.
Rubin_MDS218_final1 Managing Adverse Effects of HAART David Rubin, MD Clinical Assistant Professor of Medicine Weill Cornell Medical College Medical Director,
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
H1N1 Update Marty White October 12, H1N1 Information  Pandemic declared by World Health Organization in June 2009  The symptoms include fever,
Lupus is an autoimmune disease where the body's immune system becomes hyperactive and attacks normal, healthy tissue. This results in symptoms such as.
WHO - PSM 14/7/2005 Principles for selection of medicines Dr Mary R. Couper Quality Assurance and Safety of Medicines WHO.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
TO EVALUATE EARLY ANTIVIRAL RESPONSE AND SAFETY OF A DUAL BOOSTED PROTEASE INHIBITORS REGIMEN INCLUDING LOPINAVIR/r (LPV) PLUS AMPRENAVIR (AMP) OR FORTOVASE.
I. Jean Davis, PhD, PA, AAHIVS Manager - Clinical Services Desert AIDS Project.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Current Concepts in HIV/AIDS A Pharmacy Perspective Carol Schneiderman, Pharm D Clinical Pharmacist, University of Arizona.
+ Understanding HIV-Related Lab Tests Jordan E. Lake, MD, MSc AAHU Sept 1, 2015.
AIDS. What is AIDS  Applies to the most advanced stages of HIV infection.  CDC defines AIDS as all HIV infected people who have fewer than 200 CD4 positive.
Anti Retroviral Treatment Dr. Alap Mehta Senior Medical officer A.R.T. Centre.
HIV: WHAT IS NEW? DR NYA EBAMA, M.D. LOWCOUNTRY INFECTIOUS DISEASES, PA CARETEAM PLUS, INC SEPTEMBER 18, 2015.
11 INTRODUCTION TO ANTIRETROVIRAL THERAPY (ART) IN CHILDREN: INITIATION AND MONITORING HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Side effects of antiretroviral drugs
HIV Pharmacotherapy Focused Update
What is a vaccine? A vaccine is a medicine that's given to help prevent a disease. Vaccines help the body produce antibodies. These antibodies protect.
ALFREDO MARTINEZandCLAUDIA TORRES. Human Immunodeficiency Virus First human infection estimated around 1930 First known HIV case occurred in person who.
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
Ardis Ann Moe, M.D. UCLA CARE clinic/NEVHC Van Nuys HIV Clinic 29 August 2014.
1 Case Study Claire Biever, RN Morton Home Care Taunton, MA Linda Lebreux, RN, ACRN Medical Manager Infectious Disease Associates Taunton, MA Programs.
Drug Induced Liver Disease Tutoring
HCV Update: 18 July 2016 Ardis Ann Moe, M.D.
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
Pharmacokinetics: HIV Drugs
Updated DHHS Adult and Adolescent HIV Treatment Guidelines: Conversation with Dr. Paul Sax Presentation prepared by: Paul Sax, MD and Brian Wood, MD.
Pharmacokinetics: HIV Drugs
Answers to your questions
transmission, prognosis, and social issues
HIV/AIDS By: Khatiga Shervani , Karla Molina, Tiffany Cordero, and Claribel Torres Ms. Green and Ms. Geshke Period 3.
Antiretroviral therapy and its complications
Farinaz khan Dept of FCM
Presentation transcript:

Ardis Ann Moe, M.D. UCLA CARE Clinic/NEVHC HIV Clinic Van Nuys. 29 August 2014

 To describe the major side effects of HIV treatment  To know useful lab tests for HIV side effect monitoring  To review case studies of how to choose initial HIV regimen, and what regimen to switch to in the event of side effects  Benefits of treatment

 Fuzeon causes painful lumps on the skin that persist for weeks  Shots need to be done twice daily  Selzentry rarely causes rash; can cause orthostatic hypotension, nausea, dizziness. Cannot be used in kidney failure

As a class, they are associated with liver problems: lactic acidosis, fatty liver disease Pancreatitis—rare in most of the nucs, common in Videx and Zerit

 Most common nucleotide backbone of most HIV cocktails (part of truvada)  Causes kidney damage  Causes bone thinning  Occasional GI upset

 Emtriva (part of truvada)  Essentially as safe as Epivir, but more rash  Epivir likely the safest of all the nucs

 Abacavir: as noted, an allergic reaction for persons with genetic trait: HLAB5701  Can cause headaches  Combination drug Epzicom can cause more nausea than either drug alone

 AZT; Zidovudine: Anemia, low white cells, fatigue, headache, nausea. Muscle wasting: “AZT butt”  Facial wasting, fat loss on legs and arms

 Stavudine (Zerit)  Neuropathy, facial wasting, fat loss in legs and arms.  Side effects start after 5 months or more of use—can be used as a “bridge” drug

As a class, they all cause rash and liver inflammation

 Sustiva (part of Atripla)  Causes depression, suicidality, panic attacks, insomnia (interferes with REM sleep), vivid dreams, elevated cholesterol and triglycerides.  Controversy on whether it causes birth defects  Sold on streets as alternative to LSD

 Viramune  Most likely to cause severe rash (Stevens Johnson syndrome). Proper dosing when starting medication can make rash less likely

 Intelence  Vivid dreams, gritty taste

 Edurant  Some depression, some vivid dreams.

As a class they all cause diarrhea and occasional vivid dreams. Rarely they cause depression

 Isentress; most likely to cause diarrhea

 Elvitegravir; as part of Stribild, has drug interactions and risk of kidney and bone damage. Also causes diarrhea

 Tivicay; drug interactions, diarrhea

As a class they all cause diabetes and insulin resistance. They all cause diarrhea and GI upset

 The older drugs also raise cholesterol, triglycerides significantly (Crixivan, Invirase, Viracept, Kaletra) and can cause fat accumulation (lipodystrophy)

 For older drugs, risk of lipodystrophy 75% after 2 years of use. Approx 5% for newer PI’s

 Reyataz: can also cause yellow eyes (jaundice)  May cause confusion about liver function when patients have chronic hepatitis B or hepatitis C

 Lexiva, Prezista have significant risk of skin rash  Prezista has the worse GI side effects of all the newer PI’s

 Abacavir: HLA B5701 genetic marker of allergic reaction

 Kidney function tests: creatinine and urinalysis, especially for patients on truvada or Viread containing regimens

 Liver function tests:  Bilirubin (jaundice test) usually around 2-3 in persons on reyataz. If >3.5 then alternatives to reyataz should be used  ALT, AST especially for patients on non- nucleosides

 Note that hepatitis B usually gets better on certain HIV medications (Viread, truvada, Epivir, Emtriva)  Hepatitis C can get better on any effective HIV cocktail. (note jaundice risk with reyataz)

 CBC with platelets and differential ◦ Low platelets (bleeding risk) can improve within a few days of starting an effective HIV drug regimen ◦ AZT can initially worsen, and then improve anemia ◦ AZT can cause low white cells especially in patient with advanced AIDS

 Hemoglobin A1c, glucose  Especially for patients on PI’s

 Cholesterol, triglycerides ◦ Especially for patients on atripla and PI’s

 Plan A: “A pill A day for type A personalities” Atripla, Complera, Stribild, Triumeq ◦ Low barrier to resistance ◦ NOT for patients who are unreliable about medications or appointments

 Plan B: “Boosted protease inhibitor for batty buddies on the brink” ◦ Most useful when you have patients with OI or AIDS cancers OR mentally ill patients OR patients with other adherence risks ◦ Reyataz/norvir/truvada ◦ Prezista/norvir/truvada  High barriers to resistance.  May aggravate diabetes  Can substitute epzicom for truvada if there is kidney damage

 Plan C: “Curses, I forgot the Contraception”  Kaletra and Combivir (AZT/epivir)  First choice for pregnant women with HIV

 Plan D: for Drug-drug interactions OR DARN I stuck myself  Isentress +truvada  Has fewest drug interactions  Preferred drugs for needlestick injuries

 Diabetic:  Triumeq (dolutegravir/lamivudine/abacavir)  Stribild  Atripla  Complera  Isentress/truvada ◦ Recall that the above 4 cocktails all contain tenofovir, which can damage kidneys

 Kaletra/Combivir  Prezista/Norvir/Epzicom  Isentress/Epzicom

 32 yo homeless man, HIV+ new diagnosis.  Alcoholic, depressed, Cr 2.3 (normal 1.2). Hepatitis C.  What drugs would you try to AVOID.  What initial labs do you need to make a drug choice decision?

 65 yo male new dx of HIV infection.  Hx of cardiac disease. On amiroidarone and warfarin (coumadin).normal kidney function  Takes medications regularly  What HIV medications do you need to AVOID?  What drug cocktails can be used in him?

 31 yo pregnant woman with HIV and hepatitis C.  What are her best choices of HIV meds?

 45 yo male, new dx of HIV.  Bad heartburn, has to take twice daily protonix. Reliable on taking meds  Diabetic, on insulin  What HIV meds should he AVOID?  What cocktails can he use?

 23 yo male with HIV, on atripla for 2 years. Has creatinine increased from 1.2 to 1.5 in the past 6 months. Chronic depression, insomnia.  What other tests do you need to perform in order to change meds?  What other questions do you need to ask before changing meds?  What would be his choices for HIV meds?

 34 yo homeless man, new diagnosis of AIDS, severely anemic, +HLA B5701, Cr 2.3 (kidney damage), and severe MAC infection with CD4 count 100,000 on admission

 55 yo female with AIDS and CMV retinitis, going blind with syphilis. Homeless, cocaine addict. Normal Cr. Resistant to truvada and reyataz and norvir. CD4 count 100,000  How would you decide what, and when to change HIV meds?

 31 yo male, dx AIDS and MAC 6 months ago. Has tried multiple HIV meds.CD4 count 100,000  Allergic to efavirenz, neviripine, intelence, abacavir, truvada, norvir, prezista, kaletra, lexiva, reyataz.  What drug cocktails can still be used?

 24 yo MSM male, pre-med student, discovers he is HIV+  2 hours of counseling to prevent suicide in clinic  Later becomes a HIV testing counselor, a medical student, and then a successful physician.  Married, and now has adopted four children.

 AIDS patient in his 50’s, doing well, discovers that he is the only adult child willing to care for his demented evangelical homophobic minister father.  Dad moves into the apartment, overlooking the Gay Pride route in West Hollywood.  Dad looks out the window: “I think I hate those people but I forgot why”.

 Decide first if a patient is Plan A, B, C or D.  Evaluate renal function, diabetes issues, hepatitis, allergies, severity of HIV disease, mental illness.  Consider resistance issues and evaluate patient for ability to take medications.  Tailor HIV medications to patient’s profile  Getting older also means getting revenge!